top of page

AirLOC™

The human nasal airway is the first line of defense against airborne pathogens, and it is often the site of debilitating disorders such as asthma and rhinitis. Physiologically relevant models of the nasal airway are essential to understanding how these diseases develop, but many current models lack important dynamic conditions (such as breathing) which affect cellular function.

 

Our nasal airway-on-chip platform  can mimic the breathing airway. Using this dynamic platform, we can study how airflow affects cell behavior and investigate how healthy and diseased nasal airways are impacted by airborne particulates. 

AirLOC allows researchers to study respiratory functions and diseases in a lab setting by simulating realistic nasal airflow and blood-like conditions. This enables detailed investigation of respiratory interactions, drug responses, and disease progression in a controlled and physiologically relevant environment, reducing reliance on animal models.

Current Status

​​

 U.S. patent application (US20230383224A1) was filed on May 25, 2023, and is currently pending.

Our Partners

Balalab_White.png
White UArk logo.png
KSU-logo_edited.png
GEORGIA-FS-FC_edited_edited.jpg
bottom of page